Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
From 2022-2024 the fund was the largest shareholder, and I served on the board of Arca Biopharma, culminating in its merger with Oruka Therapeutics (ORKA). My short seller’s...
— Cable Car Capital LLC
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Oruka Therapeutics, Inc.
No other institutional pitches found for this ticker yet.
More institutional theses from Cable Car Capital / Funicular Funds